Submitted by Anonymous (not verified) on 20 September 2024 - 11:52
Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 9, Status: Authorised